Targeting protein degradation using small molecules is one of the
most exciting small-molecule therapeutic strategies in decades and
a rapidly growing area of research. In particular, the development
of proteolysis targeting chimera (PROTACs) as potential drugs
capable of recruiting target proteins to the cellular quality
control machinery for elimination has opened new avenues to address
traditionally 'difficult to target' proteins. This book provides a
comprehensive overview from the leading academic and industrial
experts on recent developments, scope and limitations in this
dynamically growing research area; an ideal reference work for
researchers in drug discovery and chemical biology as well as
advanced students.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!